172 related articles for article (PubMed ID: 15118760)
1. Antiproliferative activity of a triplex-forming oligonucleotide recognizing a Ki-ras polypurine/polypyrimidine motif correlates with protein binding.
Cogoi S; Ballico M; Bonora GM; Xodo LE
Cancer Gene Ther; 2004 Jul; 11(7):465-76. PubMed ID: 15118760
[TBL] [Abstract][Full Text] [Related]
2. G-rich oligonucleotide inhibits the binding of a nuclear protein to the Ki-ras promoter and strongly reduces cell growth in human carcinoma pancreatic cells.
Cogoi S; Quadrifoglio F; Xodo LE
Biochemistry; 2004 Mar; 43(9):2512-23. PubMed ID: 14992588
[TBL] [Abstract][Full Text] [Related]
3. Influence of GC and AT specific DNA minor groove binding drugs on intermolecular triplex formation in the human c-Ki-ras promoter.
Vigneswaran N; Mayfield CA; Rodu B; James R; Kim HG; Miller DM
Biochemistry; 1996 Jan; 35(4):1106-14. PubMed ID: 8573565
[TBL] [Abstract][Full Text] [Related]
4. (A,G)-oligonucleotides form extraordinary stable triple helices with a critical R.Y sequence of the murine c-Ki-ras promoter and inhibit transcription in transfected NIH 3T3 cells.
Alunni-Fabbroni M; Pirulli D; Manzini G; Xodo LE
Biochemistry; 1996 Dec; 35(50):16361-9. PubMed ID: 8973212
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of nuclear protein binding to the human Ki-ras promoter by triplex-forming oligonucleotides.
Mayfield C; Squibb M; Miller D
Biochemistry; 1994 Mar; 33(11):3358-63. PubMed ID: 8136373
[TBL] [Abstract][Full Text] [Related]
6. Anti-gene effect in live cells of AG motif triplex-forming oligonucleotides containing an increasing number of phosphorothioate linkages.
Cogoi S; Rapozzi V; Quadrifoglio F; Xodo L
Biochemistry; 2001 Feb; 40(5):1135-43. PubMed ID: 11170438
[TBL] [Abstract][Full Text] [Related]
7. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of c-Ki-ras promoter activity by triplex-forming oligonucleotides endogenously generated in human 293 cells.
Cogoi S; Suraci C; Del Terra E; Diviacco S; van der Marel G; van Boom J; Quadrifoglio F; Xodo L
Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):283-95. PubMed ID: 10984122
[TBL] [Abstract][Full Text] [Related]
9. Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide.
Cogoi S; Codognotto A; Rapozzi V; Meeuwenoord N; van der Marel G; Xodo LE
Biochemistry; 2005 Aug; 44(31):10510-9. PubMed ID: 16060660
[TBL] [Abstract][Full Text] [Related]
10. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.
McGuffie EM; Pacheco D; Carbone GM; Catapano CV
Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new G-quadruplex motif in the KRAS promoter and design of pyrene-modified G4-decoys with antiproliferative activity in pancreatic cancer cells.
Cogoi S; Paramasivam M; Filichev V; Géci I; Pedersen EB; Xodo LE
J Med Chem; 2009 Jan; 52(2):564-8. PubMed ID: 19099510
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cells.
Napoli S; Negri U; Arcamone F; Capobianco ML; Carbone GM; Catapano CV
Nucleic Acids Res; 2006; 34(2):734-44. PubMed ID: 16449206
[TBL] [Abstract][Full Text] [Related]
15. A kinetic study of triple-helix formation at a critical R x Y sequence of the murine c-Ki-ras promoter by (A,G)- and (G,T) oligonucleotides.
Xodo LE; Pirulli D; Quadrifoglio F
Eur J Biochem; 1997 Sep; 248(2):424-32. PubMed ID: 9346298
[TBL] [Abstract][Full Text] [Related]
16. Intra- and intermolecular triplex DNA formation in the murine c-myb proto-oncogene promoter are inhibited by mithramycin.
Vigneswaran N; Thayaparan J; Knops J; Trent J; Potaman V; Miller DM; Zacharias W
Biol Chem; 2001 Feb; 382(2):329-42. PubMed ID: 11308031
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of N-ras oncogene anti-sense, sense and nonsense sequence methylphosphonate oligonucleotide analogues.
Tidd DM; Hawley P; Warenius HM; Gibson I
Anticancer Drug Des; 1988 Aug; 3(2):117-27. PubMed ID: 2457379
[TBL] [Abstract][Full Text] [Related]
18. Guanine-rich oligonucleotides targeted to a critical R . Y site located in the Ki-ras promoter. The effect of competing self-structures on triplex formation.
Alunni-Fabbroni M; Manzini G; Quadrifoglio F; Xodo LE
Eur J Biochem; 1996 May; 238(1):143-51. PubMed ID: 8665931
[TBL] [Abstract][Full Text] [Related]
19. Formation of stable DNA triple helices within the human bcr promoter at a critical oligopurine target interrupted in the middle by two adjacent pyrimidines.
Xodo LE; Manzini G; Quadrifoglio F
Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):477-88. PubMed ID: 9918112
[TBL] [Abstract][Full Text] [Related]
20. Triplex formation inhibits HER-2/neu transcription in vitro.
Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
